Machine learning–based prognostic modeling for locally advanced non-small cell lung cancer treated with immuno-radiotherapy
The RSF model demonstrated improved performance compared to the conventional Cox model in predicting survival and stratifying risk among patients with locally advanced NSCLC undergoing CCRT and consolidation immunotherapy.
Authors
- Shanshan Lu (ORCID: https://orcid.org/0000-0001-6270-9347)
- Yi Wang (ORCID: https://orcid.org/0000-0002-2031-087X)
- Yafei Li (ORCID: https://orcid.org/0000-0002-6136-863X)
- Yan Zhang (ORCID: https://orcid.org/0000-0001-8738-2053)
- Xiaojia Yu
- Xin Zheng (ORCID: https://orcid.org/0000-0003-1384-6999)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fphar.2025.1723874
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00